Wordt geladen...
Development and Preliminary Evaluation of TFIB, a New Bimodal Prosthetic Group for Bioactive Molecule Labeling
[Image: see text] The new readily available prosthetic group, tetrafluorophenyl 4-fluoro-3-iodobenzoate (TFIB), designed for both molecular imaging and targeted radionuclide therapy purposes was radiolabeled either with fluorine or iodine radionuclides with excellent radiochemical yields and puritie...
Bewaard in:
Gepubliceerd in: | ACS Med Chem Lett |
---|---|
Hoofdauteurs: | , , , , , , , , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
American Chemical
Society
2014
|
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4329574/ https://ncbi.nlm.nih.gov/pubmed/25699145 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ml500423v |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|